Steroids in late ARDS?

Affiliations

Comment

Non Wajanaponsan et al. Crit Care. 2007.

. 2007;11(4):310.

doi: 10.1186/cc5954.

¹ Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

No abstract available

Comment on

Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome.
Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT, Ancukiewicz M; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Steinberg KP, et al. N Engl J Med. 2006 Apr 20;354(16):1671-84. doi: 10.1056/NEJMoa051693. N Engl J Med. 2006. PMID: 16625008 Clinical Trial.

1. Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT, Ancukiewicz M. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006;354:1671–1684. doi: 10.1056/NEJMoa051693. - DOI - PubMed
1. Bernard GR, Luce JM, Sprung CL, Rinaldo JE, Tate RM, Sibbald WJ, Kariman K, Higgins S, Bradley R, Metz CA. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med. 1987;317:1565–1570. - PubMed
1. Luce JM, Montgomery AB, Marks JD, Turner J, Metz CA, Murray JF. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis. 1988;138:62–68. - PubMed
1. Annane D, Sebille V, Bellissant E, Ger-Inf-05 Study Group Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med. 2006;34:22–30. doi: 10.1097/01.CCM.0000194723.78632.62. - DOI - PubMed
1. Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, Gibson M, Umberger R. Methylprednisolone Infusion in Early Severe ARDS*Results of a Randomized Controlled Trial. Chest. 2007;131:954–963. doi: 10.1378/chest.06-2100. - DOI - PubMed